Rayont Valuation
| RAYT Stock | USD 0.03 0.00 0.00% |
Rayont seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Rayont Inc from analyzing the company fundamentals such as Return On Equity of 0.19, shares outstanding of 50.16 M, and Operating Margin of (0.43) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Rayont's price fluctuation is not too volatile at this time. Calculation of the real value of Rayont Inc is based on 3 months time horizon. Increasing Rayont's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Rayont's intrinsic value may or may not be the same as its current market price of 0.03, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0291 | Real 0.0244 | Hype 0.0291 | Naive 0.0291 |
The intrinsic value of Rayont's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Rayont's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Rayont Inc helps investors to forecast how Rayont pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rayont more accurately as focusing exclusively on Rayont's fundamentals will not take into account other important factors: Rayont Total Value Analysis
Rayont Inc is at this time anticipated to have valuation of 13.09 M with market capitalization of 57.19 M, debt of 4.81 M, and cash on hands of 37.84 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Rayont fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.09 M | 57.19 M | 4.81 M | 37.84 K |
Rayont Investor Information
About 52.0% of the company outstanding shares are owned by corporate insiders. The book value of Rayont was at this time reported as 0.13. The company last dividend was issued on the 21st of May 2018. Rayont Inc had 1:20 split on the 21st of May 2018. Based on the key indicators related to Rayont's liquidity, profitability, solvency, and operating efficiency, Rayont Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Rayont Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Rayont has an asset utilization ratio of 20.01 percent. This implies that the Company is making $0.2 for each dollar of assets. An increasing asset utilization means that Rayont Inc is more efficient with each dollar of assets it utilizes for everyday operations.Rayont Ownership Allocation
Rayont owns a total of 50.16 Million outstanding shares. Rayont has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Rayont Profitability Analysis
The company reported the previous year's revenue of 2.84 M. Net Income was 244.86 K with profit before overhead, payroll, taxes, and interest of 1.38 M.About Rayont Valuation
The pink sheet valuation mechanism determines Rayont's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Rayont Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rayont. We calculate exposure to Rayont's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Rayont's related companies.Rayont Inc., through its subsidiary, THF Holdings Pty Ltd., operates as a cancer treatment and medical device company. Rayont Inc. was founded in 2011 and is based in Southport, Australia. RAYONT INC operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 3 people.
8 Steps to conduct Rayont's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Rayont's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Rayont's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Rayont's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Rayont's revenue streams: Identify Rayont's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Rayont's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Rayont's growth potential: Evaluate Rayont's management, business model, and growth potential.
- Determine Rayont's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Rayont's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Rayont Growth Indicators
Investing in growth stocks can be very risky. If the company such as Rayont does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 48.1 M | |
| Quarterly Earnings Growth Y O Y | -0.469 | |
| Retained Earnings | -3.6 M |
Additional Tools for Rayont Pink Sheet Analysis
When running Rayont's price analysis, check to measure Rayont's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rayont is operating at the current time. Most of Rayont's value examination focuses on studying past and present price action to predict the probability of Rayont's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rayont's price. Additionally, you may evaluate how the addition of Rayont to your portfolios can decrease your overall portfolio volatility.